Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi‐systematic review
暂无分享,去创建一个
[1] T. Ota,et al. Intestinal Behçet’s disease with pyoderma gangrenosum successfully treated with the combination therapy of adalimumab and glucocorticoids , 2018, Modern rheumatology.
[2] K. Kridin,et al. Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis , 2018, American Journal of Clinical Dermatology.
[3] Rosie Qin,et al. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts , 2018, JAMA dermatology.
[4] B. Feagan,et al. Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease , 2018, Digestive Diseases and Sciences.
[5] Andrew M. Armenta,et al. Delayed diagnosis of post-surgical pyoderma gangrenosum: A multicenter case series and review of literature , 2018, International journal of surgery case reports.
[6] C. Ahn,et al. Pyoderma gangrenosum: a review of pathogenesis and treatment , 2018, Expert review of clinical immunology.
[7] I. Ceccherini,et al. LPIN2 gene mutation in a patient with overlapping neutrophilic disease (pyoderma gangrenosum and aseptic abscess syndrome) , 2018, JAAD case reports.
[8] L. Misery,et al. PASH syndrome (pyoderma gangrenosum, acne and hidradenitis suppurativa): a disease with genetic heterogeneity , 2018, The British journal of dermatology.
[9] P. Lin,et al. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature , 2018, International journal of dermatology.
[10] G. Foulke,et al. Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement , 2017, JAAD case reports.
[11] P. Modiano,et al. Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndrome , 2017, JAAD case reports.
[12] S. Granter,et al. Wounds That Would Not Heal: Pyoderma Gangrenosum. , 2017, The American journal of medicine.
[13] T. Schoeller,et al. Reconstructive microsurgical approach for the treatment of pyoderma gangrenosum. , 2018, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[14] B. Tod,et al. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab. , 2017, Dermatology online journal.
[15] G. Carreño-Tarragona,et al. Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone , 2017, International wound journal.
[16] E. Çalışkan. Er: YAG Laser Ablation: An Adjuvant Treatment for Medically Resistant Pyoderma Gangrenosum. , 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[17] B. Abraham,et al. Resolution of Pyoderma Gangrenosum With Vedolizumab in a Crohnʼs Patient: 2017 Presidential Poster Award: 1973 , 2017 .
[18] Teresa Ro,et al. Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa. , 2017, The Journal of clinical and aesthetic dermatology.
[19] N. Sami,et al. Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone , 2017, JAAD case reports.
[20] J. Mascaró,et al. Multifocal and refractory pyoderma gangrenosum: Possible role of cocaine abuse , 2017, The Australasian journal of dermatology.
[21] E. Berti,et al. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis) , 2017, The British journal of dermatology.
[22] T. Ruzicka,et al. Familial Mediterranean fever patients with hidradenitis suppurativa , 2017, International journal of dermatology.
[23] P. Shetty,et al. Pyoderma gangrenosum in Sjögren's syndrome and its successful treatment with topical application of etanercept , 2017, International journal of rheumatic diseases.
[24] P. R. Mydlarski,et al. Plasmablastic-like lymphoma arising within chronic pyoderma gangrenosum , 2017, JAAD case reports.
[25] R. Seabury,et al. Severe neutrophilic dermatosis following submental deoxycholic acid administration , 2017, Clinical toxicology.
[26] M. F. Chin,et al. Successful Treatment of Autoimmune Disease-Associated Pyoderma Gangrenosum With the IL-1 Receptor Antagonist Anakinra: A Case Series of 3 Patients. , 2017, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[27] M. Beylot-Barry,et al. Pyoderma gangrenosum with extensive pulmonary involvement , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[28] R. Galimberti,et al. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients , 2017, International journal of dermatology.
[29] Jeung-Hoon Lee,et al. Treatment of Recalcitrant Pyoderma Gangrenosum with Ulcerative Colitis by Adalimumab Injection , 2017, Annals of dermatology.
[30] L. Davis,et al. A case of autoinflammatory skin and bone disease flared by a change in osteoporosis management , 2017, JAAD case reports.
[31] T. Dainichi,et al. High level of serum human interleukin‐18 in a patient with pyogenic arthritis, pyoderma gangrenosum and acne syndrome , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[32] P. Yeo,et al. Neutrophilic Dermatoses as a Continuous Spectrum: An Illustrative Case. , 2016, Annals of the Academy of Medicine, Singapore.
[33] W. Payne,et al. Severe Bilateral Lower Extremity Pyoderma Gangrenosum , 2016, Eplasty.
[34] A. Gottlieb,et al. High‐dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosum , 2016, Dermatologic therapy.
[35] A. Puri,et al. Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis , 2016, Intestinal research.
[36] R. Galimberti,et al. The role of interleukin-1β in pyoderma gangrenosum , 2016, JAAD case reports.
[37] I. Burón-Alvarez,et al. Refractory pyoderma gangrenosum treated with platelet‐rich plasma , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.
[38] Masoomeh Khajehnoori,et al. A case of surgically treated peristomal pyoderma gangrenosum in a patient with rheumatoid arthritis , 2016, Journal of surgical case reports.
[39] S. L. Ortega,et al. [Peristomal pyoderma gangrenosum after rectal adenocarcinoma in the context of colonic and complex perianal Crohn's disease]. , 2016 .
[40] D. Rigopoulos,et al. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. , 2016, Acta dermatovenerologica Croatica : ADC.
[41] D. Selva,et al. Pyoderma gangrenosum of the eyelid. , 2016, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[42] M. Schmuth,et al. Surgical treatment of pyoderma gangrenosum with negative pressure wound therapy and split thickness skin grafting under adequate immunosuppression is a valuable treatment option: Case series of 15 patients. , 2016, Journal of the American Academy of Dermatology.
[43] P. Baade,et al. Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry‐based follow‐up study , 2016, The Australasian journal of dermatology.
[44] M. Allez,et al. Certolizumab pegol – A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn’s disease , 2016, The Journal of dermatological treatment.
[45] N. De Maria,et al. Complete resolution of non‐necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection , 2016, Clinical case reports.
[46] A. Lohse,et al. [Multiple abscesses after a cruise along the Latin American coast]. , 2016, Der Internist.
[47] Dhyan Rajan,et al. IBD LIVE Case Series-Case 6. , 2016, Inflammatory bowel diseases.
[48] Víctor Amo Trillo,et al. [Peristomal pyoderma gangrenosum after rectal adenocarcinoma in the context of colonic and complex perianal Crohn's disease]. , 2016, Gastroenterologia y hepatologia.
[49] F. J. Céspedes-Guirao,et al. Management of pyoderma gangrenosum with combination of systemic treatment, vacuum-assisted closure and synthetic dermal substitute , 2016, European Journal of Plastic Surgery.
[50] A. Lohse,et al. Multiple Abszesse nach Südamerikakreuzfahrt , 2016, Der Internist.
[51] W. Koltun,et al. Refractory Peristomal Pyoderma Gangrenosum Successfully Treated With Intravenous Immunoglobulin: A Case Report , 2015, The American Journal of Gastroenterology.
[52] S. Goerdt,et al. Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[53] B. Xia,et al. Pyoderma gangrenosum of articulations carpi associated with ulcerative colitis: one case report. , 2015, International journal of clinical and experimental medicine.
[54] M. Camilleri,et al. Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014. , 2015, Journal of the American Academy of Dermatology.
[55] C. Zouboulis,et al. Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab. , 2015, Journal of dermatological case reports.
[56] E. Lindwall,et al. Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome. , 2015, Seminars in arthritis and rheumatism.
[57] Toshiyuki Yamamoto,et al. Peristomal pyoderma gangrenosum: A report of three cases , 2015, The Journal of dermatology.
[58] H. Williams,et al. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial , 2015, BMJ : British Medical Journal.
[59] E. Bendia,et al. Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[60] M. Gonçalo,et al. Pyoderma gangrenosum: challenges and solutions , 2015, Clinical, cosmetic and investigational dermatology.
[61] E. Maverakis,et al. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. , 2015, Acta dermato-venereologica.
[62] D. Meyersburg. Multilokuläres superfizielles Pyoderma gangraenosum oder PAPA-Syndrom – erfolgreiche Therapie mit Ustekinumab , 2015, Aktuelle Dermatologie.
[63] O. Hilberg,et al. Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature. , 2015, Respiratory medicine.
[64] G. Carretero-Hernández,et al. Infliximab como opción terapéutica en pioderma gangrenoso mamario bilateral postquirúrgico refractario , 2015 .
[65] R. McDonald,et al. Recalcitrant pyoderma gangrenosum treated with parenteral iron sucrose therapy , 2015, JAAD case reports.
[66] N. Parrish,et al. Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and Metronidazole , 2015, Case Reports in Gastroenterology.
[67] Han Pei-pe. Pyoderma gangrenosum associated with inflammatory bowel disease , 2015 .
[68] J. L. P. L. Peña,et al. Enfermedad de Behçet y pioderma gangrenoso refractario a terapia convencional con respuesta a infliximab , 2015 .
[69] S. Chimenti,et al. PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition. , 2015, Journal of the American Academy of Dermatology.
[70] M. Sánchez-Conde,et al. Behçet disease and refractory pyoderma gangrenosum with response to infliximab. , 2015, Revista clinica espanola.
[71] K. Chayama,et al. Successful Use of Adalimumab for Treating Pyoderma Gangrenosum with Ulcerative Colitis under Corticosteroid-tapering Conditions. , 2015, Internal medicine.
[72] A. Gaspari,et al. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab. , 2015, Cutis.
[73] G. Zerboni,et al. Cutaneous manifestations and gastrointestinal disorders: Report of two emblematic cases. , 2015, La Clinica terapeutica.
[74] L. Rönnblom,et al. Recurrent pyoderma gangrenosum and cystic acne associated with leucocyte adhesion deficiency due to novel mutations in ITGB2: successful treatment with infliximab and adalimumab. , 2015, Acta dermato-venereologica.
[75] G. Morrison,et al. Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis , 2015, International Journal of Colorectal Disease.
[76] Mio Nakamura,et al. Pyoderma Gangrenosum Following the Revision of a Breast Reconstruction and Abdominoplasty , 2014 .
[77] D. Fanoni,et al. Association of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Shares Genetic and Cytokine Profiles With Other Autoinflammatory Diseases , 2014, Medicine.
[78] M. Ye,et al. Pyoderma Gangrenosum: A Review of Clinical Features and Outcomes of 23 Cases Requiring Inpatient Management , 2014, Dermatology research and practice.
[79] D. Fanoni,et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome , 2014, Clinical and experimental immunology.
[80] E. Cinotti,et al. Certolizumab for the treatment of refractory disseminated pyoderma gangrenosum associated with rheumatoid arthritis , 2014, Clinical and experimental dermatology.
[81] N. Teich. Failure of sublesional infliximab injection for refractory parastomal pyoderma gangrenosum in a patient with Crohn’s disease , 2014, Techniques in Coloproctology.
[82] C. GuillermoBannura,et al. PIODERMA GANGRENOSO GIGANTE DE CURSO FULMINANTE ASOCIADO A ENFERMEDAD INFLAMATORIA INTESTINAL , 2014 .
[83] Recep Ak,et al. A case of granulomatosis with polyangiitis and pyoderma gangrenosum successfully treated with infliximab and rituximab. , 2014, International journal of rheumatic diseases.
[84] N. Yun,et al. Peritonsillar Involvement in Pyoderma Gangrenosum associated with Ulcerative Colitis , 2014, Intestinal research.
[85] M. Morgan,et al. A report of two patients with a history of pyoderma gangrenosum where total knee arthroplasty was performed under prophylactic immunosuppression , 2014 .
[86] C. Lyon,et al. Severe Back Pain in a Young Patient with Pyoderma Gangrenosum and Crohn’s Disease Controlled with Anti-tumor Necrosis Factor Therapy: Sterile Osteomyelitis , 2014, Dermatology and Therapy.
[87] Hyun Jong Lee,et al. Zosteriform transient acantholytic dermatosis , 2014, The Journal of dermatology.
[88] N. Teich,et al. Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis. , 2014, Journal of Crohn's & colitis.
[89] O. Ishikawa,et al. Clinical analysis of leg ulcers and gangrene in rheumatoid arthritis , 2013, The Journal of dermatology.
[90] P. Gjersvik,et al. [A horseshoe-shaped wound on the back]. , 2013, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[91] A. Swaminath,et al. Gastrointestinal: Severe inflammatory bowel disease‐associated pyoderma gangrenosum , 2013, Journal of gastroenterology and hepatology.
[92] Jack Green,et al. Mycophenolate use in dermatology: A clinical audit , 2013, The Australasian journal of dermatology.
[93] J. Mekkes,et al. Six patients with pyoderma gangrenosum successfully treated with infliximab , 2013, International journal of dermatology.
[94] D. Alpert,et al. Refractory postsurgical pyoderma gangrenosum in a patient with Beckwith Wiedemann syndrome: response to multimodal therapy , 2013, BMJ Case Reports.
[95] Saleh Elwir,et al. A Case Report of a Patient with Crohnʼs Disease Complicated by Pyoderma Gangrenosum Treated with Intravenous Immunoglobulin: 1419 , 2013 .
[96] Mardem Machado de Souza,et al. Biological therapy for pyoderma gangrenosum , 2013 .
[97] J. Klode,et al. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients , 2013, Orphanet Journal of Rare Diseases.
[98] Daniela Simian,et al. [Treatment of inflammatory bowel disease with infliximab: experience in 25 patients]. , 2013, Revista medica de Chile.
[99] S. Sinha,et al. Pyoderma gangrenosum: guideline for wound practitioners. , 2013, Journal of wound care.
[100] T. Lobaton,et al. Characteristics and Treatment of Pyoderma Gangrenosum in Inflammatory Bowel Disease , 2013, Digestive Diseases and Sciences.
[101] L. Guidi,et al. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery. , 2013, Journal of Crohn's & colitis.
[102] S. Katz,et al. Massive pyoderma gangrenosum in a 77 year old female with Crohn's disease responsive to adalimumab. , 2013, Journal of Crohn's & colitis.
[103] M. Figueira,et al. N015 Patient education on their disease as a determinant on the progression of complications. The role of specialized nursing , 2013 .
[104] Tomoyuki Ito,et al. A case of aseptic abscesses syndrome treated with corticosteroids and TNF-alpha blockade , 2013, Modern rheumatology.
[105] R. Quera,et al. [Treatment of inflammatory bowel disease with infliximab: experience in 25 patients]. , 2013, Revista medica de Chile.
[106] E. El-Omar,et al. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s Disease , 2013, BMC Research Notes.
[107] B. Rao,et al. Superficial pyoderma gangrenosum treated with infliximab: a case report. , 2012, Cutis.
[108] V. Bruzzese. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy. , 2012, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[109] A. Gottlieb,et al. Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab. , 2012, Journal of the American Academy of Dermatology.
[110] R. Guedes,et al. Treatment of thalidomide resistant pyoderma gangrenosum with etenercept. , 2012, Acta dermatovenerologica Croatica : ADC.
[111] S. Glover,et al. IVIG Treatment for Refractory Pyoderma Gangrenosum in Patients with Inflammatory Bowel Disease: 1265 , 2012 .
[112] N. Nguyen,et al. A large shin ulcer after minor trauma: please do not debride! , 2012, Gastroenterology.
[113] M. Cottone,et al. Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin. , 2012, Inflammatory bowel diseases.
[114] M. Cordero-Coma,et al. Refractory Pyoderma Gangrenosum of the Orbit and the Lacrimal Sac , 2012, Orbit.
[115] S. D. Del Giacco,et al. Idiopathic pyoderma gangrenosum: successful resolution with infliximab therapy and pro-inflammatory cytokines assessment. , 2012, Acta dermato-venereologica.
[116] A. Pandya,et al. The use of etanercept in the treatment of peristomal pyoderma gangrenosum , 2012, Clinical and experimental dermatology.
[117] E. Makino,et al. Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease , 2012, The Journal of dermatology.
[118] T. Vogt,et al. Adalimumab: a Treatment Option for Pyoderma Gangrenosum After Failure of Systemic Standard Therapies , 2012, Dermatology and Therapy.
[119] Brian L. Huang,et al. Facial ulceration in a patient with Crohn's disease. , 2012, Gastroenterology.
[120] J. J. S. Maestrojuan,et al. Pioderma gangrenoso asociado a enfermedad inflamatoria intestinal. Descripción de 2 casos con buena respuesta a infliximab , 2012 .
[121] R. Owen,et al. Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosum , 2012, Clinical and experimental dermatology.
[122] C. Cubero,et al. Pyoderma Gangrenosum Associated With Inflammatory Bowel Disease. Report of Two Cases With Good Response to Infliximab , 2012 .
[123] M. Tanioka,et al. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab. , 2012, Dermatology online journal.
[124] M. Hoang,et al. Case records of the Massachusetts General Hospital. Case 1-2012. An 82-year-old man with persistent ulcers on the hands. , 2012, The New England journal of medicine.
[125] R. Bosch,et al. [Pyoderma gangrenosum: a report of 15 cases and review of the literature]. , 2012, Actas dermo-sifiliograficas.
[126] E. Doménech,et al. Adalimumab for pyoderma gangrenosum associated with inflammatory bowel disease. , 2011, Inflammatory bowel diseases.
[127] I. Klein,et al. "Fulminant" Behçet disease. , 2011, Presse medicale.
[128] A. Langewouters,et al. Severe pyoderma gangrenosum unresponsive to etanercept and adalimumab , 2011, The Journal of dermatological treatment.
[129] J. Grant-Kels,et al. Cutaneous simulants of infectious disease , 2011, International journal of dermatology.
[130] N. Teich. Infliximab anaphylaxis in siblings. , 2011, Inflammatory bowel diseases.
[131] J. Aitken,et al. Body‐site distribution of skin cancer, pre‐malignant and common benign pigmented lesions excised in general practice , 2011, The British journal of dermatology.
[132] Zhenwu Lin,et al. Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 gene. , 2011, Inflammatory bowel diseases.
[133] I. Katayama,et al. Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid‐resistant pyoderma gangrenosum associated with inflammatory bowel disease , 2011, The Journal of dermatology.
[134] P. Itin,et al. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents. , 2011, Advances in skin & wound care.
[135] E. Mazokopakis,et al. Improvement of ulcerative pyoderma gangrenosum with hyperbaric oxygen therapy , 2011, Dermatologic therapy.
[136] E. Ben-Chetrit,et al. Laryngeal involvement in Behcet’s disease—a challenge for treatment , 2013, Clinical Rheumatology.
[137] T. Maurer,et al. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. , 2010, Archives of dermatology.
[138] F. Baglieri,et al. THERAPEUTIC HOTLINE: Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report , 2010, Dermatologic therapy.
[139] R. Chalmers,et al. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab. , 2010, Dermatology online journal.
[140] Hiroaki Nakamura,et al. Use of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritis , 2010, Modern rheumatology.
[141] T. Shaver,et al. Clinical efficacy of etanercept for treatment of PAPA syndrome. , 2010, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[142] I. Pedro,et al. Utilidad del infliximab en pioderma gangrenoso no asociado a enfermedad inflamatoria intestinal , 2010 .
[143] Parviz Goshtasby,et al. A novel approach to the management of pyoderma gangrenosum complicating reduction mammaplasty. , 2010, Aesthetic surgery journal.
[144] E. Efremidou,et al. Crohn's Disease Associated Pyoderma Gangrenosum Treated with Adalimumab , 2010 .
[145] Y. Bar-dayan,et al. Coexistent pyoderma gangrenosum and tibialis anterior myositis as presenting manifestations of Crohn’s disease: case report and review of the literature , 2011, Rheumatology International.
[146] M. English,et al. A CASE OF PYODERMA GANGRENOSUM OF THE LUNG , 2009 .
[147] F. Castiglione,et al. Monster parastomal pyoderma gangrenosum effectively treated by topical tacrolimus. , 2009, Journal of Crohn's & colitis.
[148] R. Sarkany,et al. Superficial granulomatous pyoderma treated preoperatively with infliximab , 2009, Clinical and experimental dermatology.
[149] J. Callen,et al. Mycophenolate mofetil as therapy for pyoderma gangrenosum. , 2009, Archives of dermatology.
[150] D. Moher,et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.
[151] N. Alkhouri,et al. Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease. , 2009, Inflammatory bowel diseases.
[152] Z. Barta,et al. Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone. , 2009, World journal of gastroenterology.
[153] Byung Soo Kim,et al. A Case of Recalcitrant Pyoderma Gangrenosum Treated by Infliximab. , 2009 .
[154] M. Schaller,et al. Septic shock after treatment of pyoderma gangrenosum with infliximab. , 2009, Acta dermato-venereologica.
[155] F. Ermiş,et al. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis. , 2008, Inflammatory bowel diseases.
[156] Antonio Rodríguez,et al. Response to Infliximab in Atypical Pyoderma Gangrenosum Associated With Ulcerative Colitis , 2008, The American Journal of Gastroenterology.
[157] L. Barnes,et al. Pyoderma gangrenosum manifesting as a cavitating lung lesion , 2008, Clinical and experimental dermatology.
[158] R. Kirsner,et al. Pyoderma Gangrenosum in a Patient with Bruton's X-linked Agammaglobulinemia: Shared Pathogenesis of Altered Tumor Necrosis Factor Alpha? , 2008, The Journal of clinical and aesthetic dermatology.
[159] N. Kang,et al. Treatment of pyoderma gangrenosum with the anti-TNFalpha drug - Etanercept. , 2008, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[160] T. Gambichler,et al. Intravenous immunoglobulin for pyoderma gangrenosum , 2008, The British journal of dermatology.
[161] A. Marzano,et al. Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10‐year history with a recent response to infliximab , 2008, Clinical and experimental dermatology.
[162] F. Kerdel,et al. Pyoderma gangrenosum – rebel without a cure? , 2008, International journal of dermatology.
[163] W. Koltun,et al. Management of peristomal pyoderma gangrenosum. , 2008, Journal of the American College of Surgeons.
[164] E. Adışen,et al. Treatment of Idiopathic Pyoderma Gangrenosum with Infliximab: Induction Dosing Regimen or On-Demand Therapy? , 2008, Dermatology.
[165] J. Sánchez-Carazo,et al. [Two cases of eruptive pyoderma gangrenosum associated with cocaine use]. , 2008, Actas dermo-sifiliograficas.
[166] A. Qureshi,et al. Adalimumab for treatment of pyoderma gangrenosum , 2007, The British journal of dermatology.
[167] D. Sánchez-Muñoz,et al. Improving Transparency in Medical Journals , 2007, The American Journal of Gastroenterology.
[168] S. Moschella. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases , 2007, International journal of dermatology.
[169] T. Gress,et al. Simultaneous Onset of Ulcerative Colitis and Disseminated Pyoderma Gangrenosum , 2007, Case Reports in Gastroenterology.
[170] R. Caprilli,et al. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. , 2007, Inflammatory bowel diseases.
[171] R. Kirsner,et al. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series , 2007, International journal of dermatology.
[172] F. Luyten,et al. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis , 2007, Clinical Rheumatology.
[173] S. Christen-Zäch,et al. Infliximab for the Treatment of Disseminated Pyoderma Gangrenosum Associated with Ulcerative Colitis , 2007, Dermatology.
[174] S. Bombardieri,et al. Improvement of Idiopathic Pyoderma Gangrenosum During Treatment With Anti-Tumor Necrosis Factor Alfa Monoclonal Antibody , 2007, The international journal of lower extremity wounds.
[175] C. Tait,et al. Use of infliximab in pyoderma gangrenosum , 2007, The Australasian journal of dermatology.
[176] J. Gisbert,et al. Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis: response to infliximab. , 2007, Inflammatory bowel diseases.
[177] D. I. Smith,et al. Adalimumab treatment for pyoderma gangrenosum. , 2007, Archives of dermatology.
[178] R. Golouh,et al. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease. , 2006, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.
[179] B. Ehst,et al. Adalimumab Therapy for Recalcitrant Pyoderma Gangrenosum , 2006, Journal of burns and wounds.
[180] M. Novelli,et al. An exuberant inflammatory response to E coli: implications for the pathogenesis of ulcerative colitis and pyoderma gangrenosum , 2006, Gut.
[181] M. Rice,et al. Wet colostomy and peristomal skin breakdown. , 2006, Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society.
[182] M. Kaatz,et al. Fatal outcome of pyoderma gangrenosum with multiple organ involvement and partially responding to Infliximab , 2006 .
[183] D. Cohen,et al. The treatment of pyoderma gangrenosum using etanercept. , 2006, Journal of the American Academy of Dermatology.
[184] S. Abramson,et al. Treatment of Pyoderma Gangrenosum (PG) with Infliximab in Leukocyte Adhesion Deficiency (LAD) Type 1 , 2006 .
[185] M. Blanes,et al. Pyoderma gangrenosum treated with anti‐TNF alpha therapy (etanercept) , 2006, Clinical and experimental dermatology.
[186] J. Sánchez-Carazo,et al. Systemic absorption of topical tacrolimus in Pyoderma gangrenosum. , 2006, Acta dermato-venereologica.
[187] G. I. Leontiadis,et al. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report. , 2005, Romanian journal of gastroenterology.
[188] A. Forbes,et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial , 2005, Gut.
[189] M. Kaur,et al. Severe recalcitrant pyoderma gangrenosum treated with infliximab , 2005, The British journal of dermatology.
[190] R. Kelly,et al. Pyoderma gangrenosum complicated by herpes simplex virus infection , 2005, The Australasian journal of dermatology.
[191] R. Kirsner,et al. Refractory pyoderma gangrenosum peristomal ulcer and sinus tract treated with micronized cadaveric dermis. , 2005, Journal of the American Academy of Dermatology.
[192] A. Krag,et al. [Treatment with infliximab of peristomal pyoderma gangrenosum in ulcerative colitis]. , 2005, Ugeskrift for laeger.
[193] V. Hubbard,et al. Systemic pyoderma gangrenosum responding to infliximab and adalimumab , 2005, The British journal of dermatology.
[194] I. Uthman,et al. Successful treatment of recalcitrant pyoderma gangrenosum with infliximab complicated by tuberculosis despite negative screening tests , 2005, Clinical and experimental dermatology.
[195] A. Hoffbrand,et al. Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab , 2005, Clinical and experimental dermatology.
[196] F. Castiglione,et al. Infliximab in the treatment of extra‐intestinal manifestations of Crohn's disease , 2005, Scandinavian journal of rheumatology.
[197] G. Goldenberg,et al. Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis , 2005, The Journal of dermatological treatment.
[198] M. Yaron,et al. The effect of infliximab on extraintestinal manifestations of Crohn’s disease , 2005, Rheumatology International.
[199] I. Lawrance. INFLIXIMAB IN THE MANAGEMENT OF THE EXTRA‐INTESTINAL MANIFESTATIONS OF CROHN's DISEASE , 2004, Journal of gastroenterology and hepatology.
[200] Sidney R. Cohen,et al. Treatment of Pyoderma Gangrenosum with Infliximab in Crohn's Disease , 2004, Digestive Diseases and Sciences.
[201] F. Bermejo,et al. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab. , 2004, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
[202] Madhuri Reddy,et al. Rheumatoid arthritis‐associated inflammatory leg ulcers: a new treatment for recalcitrant wounds , 2004, International wound journal.
[203] J. Lear,et al. Infliximab as a treatment for recalcitrant pyoderma gangrenosum , 2004, Clinical and experimental dermatology.
[204] G. Schuler,et al. Successful treatment of therapy‐resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody) , 2004, The British journal of dermatology.
[205] G. Cuppari,et al. Successful use of etanercept in a patient with pyoderma gangrenosum complicating rheumatoid arthritis. , 2004, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[206] I. Grosman,et al. Control of hemorrhage from a gastric Dieulafoy's lesion using argon plasma coagulation , 2003, American Journal of Gastroenterology.
[207] M. Regueiro,et al. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease , 2003, American Journal of Gastroenterology.
[208] D. Mimouni,et al. Infliximab for peristomal pyoderma gangrenosum , 2003, The British journal of dermatology.
[209] R. Kirsner,et al. Infliximab: A Treatment Option for Ulcerative Pyoderma Gangrenosum , 2003 .
[210] F. Grange,et al. Corticosteroid-Resistant Pyoderma gangrenosum Associated with Crohn’s Disease: Rapid Cure with Infliximab , 2002, Dermatology.
[211] M. Romero-Gómez,et al. Infliximab induces remission of pyoderma gangrenosum. , 2002, European journal of gastroenterology & hepatology.
[212] M. Vatn,et al. Pyoderma Gangrenosum Associated with Crohn Disease: Effect of TNF- α Blockade with Infliximab , 2002, Scandinavian journal of gastroenterology.
[213] J. Triantafillidis,et al. Favorable Response to Infliximab Treatment in a Patient with Active Crohn Disease and Pyoderma Gangrenosum , 2002, Scandinavian journal of gastroenterology.
[214] M. Vatn,et al. Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab. , 2002, Scandinavian journal of gastroenterology.
[215] D. Sheldon,et al. Peristomal pyoderma gangrenosum. , 2001, Journal of the American College of Surgeons.
[216] O. Ennis,et al. Para-ileostomy pyoderma gangrenosum , 2001, The Lancet.
[217] M. Lebwohl,et al. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. , 2001, Archives of dermatology.
[218] S. Hanauer,et al. Treatment of pyoderma gangrenosum (PG) complicating Crohn's disease (CD) with infliximab , 2001 .
[219] J. Callen,et al. Clinical features and treatment of peristomal pyoderma gangrenosum. , 2000, JAMA.
[220] R. Kozarek,et al. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management. , 2000, Archives of surgery.
[221] M. Lebwohl,et al. Cutaneous manifestations of inflammatory bowel disease , 2000, Journal of the European Academy of Dermatology and Venereology : JEADV.
[222] D. S. Santa Cruz,et al. Neutrophilic dermatoses. , 1989, Seminars in dermatology.
[223] F. Suchy,et al. Pustular pyoderma gangrenosum associated with ulcerative colitis in childhood. Report of two cases and review of the literature. , 1986, Journal of the American Academy of Dermatology.